Currently, there's only one drug on the market that's FDA-approved to treat postpartum depression. The drug, called Zulresso, is only available through 60-hour, one-time infusion, and can cost as ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression ...

The FDA approved the first pill to treat postpartum depression on Aug. 4, offering a new treatment option for 500,000 women who develop the condition annually.

The FDA approved Zulresso, the first treatment specifically intended for women with postpartum depression. Zulresso is also the first drug developed by and approved from Sage Therapeutics, a ...

TMS is FDA-approved, which means they’ve done studies not only on how well it works, but on its safety. There are single cases of severe side effects, but they’re very rare.

A new patch to treat severe adult depression was recently approved by the Food and Drug Administration, similar to the Nicotine patch and birth-control patch, will allow patients to have more dietary ...

Unlike the Prism for PTSD protocol, the depression version is still awaiting FDA clearance. However, it’s considered a low-risk medical device, allowing it to be marketed and used in psychiatry ...

FDA issues warning for unapproved chemical being used for anxiety, depressionPhase one of Evergreen Bike Park opening Aug. 21 in Rothschild ...

The US Food and Drug Administration (FDA) granted 510K clearance to market a new transcranial magnetic stimulation (TMS) device, the MagVita TMS Therapy system from MagVenture, for treatment of ...

Compass said it plans to discuss these “preliminary COMP005 data” with the FDA, which “has not yet reviewed” the findings. “As we continue our phase 3 program, we are very encouraged by ...

The FDA's action was based on data from 2 phase 3 clinical studies of 939 patients with refractory MDD, showing that the addition of extended-release quetiapine to antidepressant therapy yielded ...

By applying for FDA approval to treat suicidal depression with NRX-100, the Company hopes to make this potentially life-saving therapy available to all Americans, not just those who are able to ...